Company:  GT BIOPHARMA, INC. (GTBP)
Form Type:  10-K
Filing Date:  3/27/2020 
CIK:  0000109657 
Address:  310 N. WESTLAKE BLVD.
SUITE 206
 
City, State, Zip:  WESTLAKE VILLAGE, California 91362 
Telephone:  (800) 304-9888 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$0.18  
Change: 
-0.0162 (-8.13%)  
Trade Time: 
02:13 PM EST  
Market Cap: 
$13.65M
Trade GTBP now with 

© 2020  
Description of Business
We are a clinical stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products based off our proprietary Tri-specific Killer Engager (TriKE(TM)), Tetra-specific Killer Engager (TetraKE(TM)) and bi-specific ligand-directed single-chain fusion protein technology platforms. Our TriKE and TetraKE platforms generate proprietary therapeutics designed to harness and enhance the cancer killing abilities of a patient's own natural killer cells, or NK cells. Once bound to an NK cell, our moieties are designed to enhance the NK cell, and precisely direct it to one or more specifically-targeted proteins expressed on a specific type of cancer cell or virus infected cell, ultimately resulting in the targeted cell's death.
Register and access this filing in:     
  FORM 10-K
    PART I
      ITEM 1. BUSINESS
      ITEM 1A. RISK FACTORS
      ITEM 1B. UNRESOLVED STAFF COMMENTS
      ITEM 2. PROPERTIES
      ITEM 3. LEGAL PROCEEDINGS
      ITEM 4. MINE SAFETY DISCLOSURES
    PART II
      ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED ...
      ITEM 6. SELECTED FINANCIAL DATA
      ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
        Results of Operations
        Liquidity and Capital Resources
      ITEM 7A QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
      ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ...
      ITEM 9A. CONTROLS AND PROCEDURES
      ITEM 9B. OTHER INFORMATION
    PART III
      ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
        NAME AND TITLE
      ITEM 11. EXECUTIVE COMPENSATION
        COMPENSATION TABLE
      ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND ...
        BENEFICIAL OWNERS
        BENEFICIAL OWNERS
      ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS AND ...
      ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES
    PART IV
      ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES
    EXHIBIT INDEX
    SIGNATURES
    REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
    BALANCE SHEET
    STOCKHOLDERS EQUITY
  EXHIBIT 31.1
    CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT.
  EXHIBIT 31.2
    CERTIFICATION PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT.
  EXHIBIT 32.1
    CERTIFICATION TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  EXHIBIT 32.2
    CERTIFICATION TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002